Denna sida på svenska

Anders Johansson

Associated

Visiting address : Neurologiska kliniken ; Karolinska universitetssjukhuset Solna, 17176 Stockholm, Sweden
Postal address : Department of Clinical Neuroscience (CNS), K8, Neuro Svenningsson, Neurologiska kliniken, Karolinska universitetssjuhuset Solna, 17176 Stockholm, Sweden
Delivery address : Neurologiska kliniken ; Karolinska universitetssjukhuset Solna, 17176 Stockholm, Sweden

Publications

Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs
Pålhagen Se, Sydow O, Johansson A, Nyholm D, Holmberg B, Widner H, et al
Parkinsonism & related disorders 2016;29():17-23

Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden
Ran C, Brodin L, Forsgren L, Westerlund M, Ramezani M, Gellhaar S, et al
Neurobiology of aging 2016;45():212.e5-212.e11

A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial
Rystedt A, Zetterberg L, Burman J, Nyholm D, Johansson A
Clinical neuropharmacology 2015;38(5):170-6

Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease
Memedi M, Sadikov A, Groznik V, Žabkar J, Možina M, Bergquist F, et al
Sensors (Basel, Switzerland) 2015;15(9):23727-44

Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease
Memedi M, Nyholm D, Johansson A, Pålhagen S, Willows T, Widner H, et al
IEEE journal of biomedical and health informatics 2015;19(6):1829-34

Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients
Nyholm D, Odin P, Johansson A, Chatamra K, Locke C, Dutta S, et al
The AAPS journal 2013;15(2):316-23

The HLA-DRA variation rs3129882 is not associated with Parkinson's disease in Sweden
Ran C, Willows T, Sydow O, Johansson A, Söderkvist P, Dizdar N, et al
Parkinsonism & related disorders 2013;19(7):701-2

Complexity of Motor Response to Different Doses of Duodenal Levodopa Infusion in Parkinson Disease
Nyholm D, Johansson A, Aquilonius Sm, Hellquist E, Lennernas H, Askmark H
CLINICAL NEUROPHARMACOLOGY 2012;35(1):6-14

Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease
Pålhagen Se, Dizdar N, Hauge T, Holmberg B, Jansson R, Linder J, et al
Acta neurologica Scandinavica 2012;126(6):e29-33

Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease
Nyholm D, Klangemo K, Johansson A
European journal of neurology 2012;19(8):1079-85

Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial
Nyholm D, Johansson A, Lennernas H, Askmark H
EUROPEAN JOURNAL OF NEUROLOGY 2012;19(6):820-6

A new computer method for assessing drawing impairment in Parkinson's disease
Westin J, Ghiamati S, Memedi M, Nyholm D, Johansson A, Dougherty M, et al
JOURNAL OF NEUROSCIENCE METHODS 2010;190(1):143-8

Circadian Rhythmicity in Levodopa Pharmacokinetics in Patients With Parkinson Disease
Nyholm D, Lennernas H, Johansson A, Estrada M, Aquilonius Sm
CLINICAL NEUROPHARMACOLOGY 2010;33(4):181-5

[(11)C]-PIB imaging in patients with Parkinson's disease: preliminary results
Johansson A, Savitcheva I, Forsberg A, Engler H, Långström B, Nordberg A, et al
Parkinsonism & related disorders 2008;14(4):345-7

Enteral Levodopa/Carbidopa infusion in advanced Parkinson disease: Long-term exposure
Nyholm D, Lewander T, Johansson A, Lewitt Pa, Lundqvist C, Aquilonius Sm
CLINICAL NEUROPHARMACOLOGY 2008;31(2):63-73

Evidence for astrocytosis in ALS demonstrated by [C-11](L)-deprenyl-D2 PET
Johansson A, Engler H, Blomquist G, Scott B, Wall A, Aquilonius Sm, et al
JOURNAL OF THE NEUROLOGICAL SCIENCES 2007;255(1-2):17-22

Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry
Ramström M, Ivonin I, Johansson A, Askmark H, Markides Ke, Zubarev R, et al
Proteomics 2004;4(12):4010-8

Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis
Johansson A, Larsson A, Nygren I, Blennow K, Askmark H
NEUROREPORT 2003;14(14):1867-9

VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis
Nygren I, Larsson A, Johansson A, Askmark H
NEUROREPORT 2002;13(17):2199-201

Parkinsonism and neck extensor myopathy - A new syndrome or coincidental findings?
Askmark H, Eeg-olofsson Ke, Johansson A, Nilsson P, Olsson Y, Aquilonius Sm
ARCHIVES OF NEUROLOGY 2001;58(2):232-7

GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis
Grundstrom E, Lindholm D, Johansson A, Blennow K, Askmark H
NEUROREPORT 2000;11(8):1781-3

Show all publications